Zura Bio Limited (ZURA) annual cash flow statement — 5-year operating, investing & financing history
| Cash from Operations | -72.67M | -64.81M | -28.08M | -15.05M | -1.2M | -1.1M |
| Operating CF Margin % | - | - | - | - | - | - |
| Operating CF Growth % | -492.32% | -130.86% | -86.5% | -1152.41% | -9.46% | - |
| Net Income | -75.43M | -68.65M | -52.4M | -60.56M | -27.33M | 8.42M |
| Depreciation & Amortization | 56K | 49K | 9K | 0 | 0 | 0 |
| Stock-Based Compensation | 11.32M | 12.33M | 16.8M | 9.65M | 334K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -555K | -4.91M | 5.21M | 30.74M | 22.26M | -9.28M |
| Working Capital Changes | -6.07M | -3.63M | 2.31M | 5.12M | 3.54M | -235.6K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 2.87K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -4.96M | -2.16M | 4.21M | 0 | 288.29K | 0 |
| Cash from Investing | -77K | -113K | -5.08M | -8M | -12M | -139.38M |
| Capital Expenditures | -77K | -113K | -75K | -8M | -12M | 0 |
| CapEx % of Revenue | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -5M | 0 | 0 | 0 |
| Cash from Financing | 127.78M | -2.16M | 109.84M | 121.29M | 14.77M | 141.21M |
| Debt Issued (Net) | -90K | 0 | 0 | -10M | 7.6M | -117.38K |
| Equity Issued (Net) | 135.23M | 5.2M | 60.76M | 116.41M | 10M | 140.82M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -7.37M | -7.37M | 49.09M | 14.89M | -2.83M | 505K |
| Net Change in Cash | 55.02M | -67.09M | 76.69M | 98.24M | 1.57M | 729.22K |
| Free Cash Flow | -72.75M | -64.93M | -28.15M | -23.05M | -13.2M | -1.1M |
| FCF Margin % | - | - | - | - | - | - |
| FCF Growth % | -112.27% | -130.64% | -22.11% | -74.63% | -1102.2% | - |
| FCF per Share | -0.65 | -0.69 | -0.37 | -0.70 | -0.77 | -0.06 |
| FCF Conversion (FCF/Net Income) | 0.96x | 0.94x | 0.54x | 0.25x | 0.05x | -0.13x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ZURA stock.
Zura Bio Limited (ZURA) generated $-64.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Zura Bio Limited (ZURA) reported negative free cash flow of $64.9M in 2025, indicating capital requirements exceeded cash from operations.
Zura Bio Limited (ZURA) spent $0.1M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.